some news, page-4

Don't hold me to this, but from memory, there is a core sample of 80 patients that have been selected for the current trials. The trial is a double blind placebo trial conducted under strict control, overseen by impartial observers. There is a great deal of financial gain at stake with these drug developement companies as you can well imagine, so control is tight. You are probably wondering that if the drug is in human trials then there must be a certain amount of confidence to get this far and you are correct in thinking this. This stage of trial predominantly is to determine efficacy and level of safety in humans. Have you logged onto the Prana Web site? If not, then it is highly recommended that you do as a starting base for your research. If you do get onto the Prana web site have a listen to the presentation given in Monaco and stay tuned for the up-coming presentation in the US.
As far as other trials. There have been and still are similar conducted by other companies who are also in pursuit of a treatement for AD and other age related degenerative deseases. However, Prana seem to have the edge which is explained on their site as well as by some of the more knowledgeable members on this forum like macrae12.
Now, as an aside, there is an 'Urban Myth' going around about another trial being organized here in Australia. This trial is meant to run concurrently with the current trials in the EU or it is being set up to take off as soon as the forth qtr results are announced. I am neither confirming or disputing the rumours so as always, DYOR

M.W.